ASHLEY WILLIAMS: Open Payments
NPI 1902522261 · PENNDEL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,763 in 81 payments from 11 companies in 2025. Trend: 2023 $617 · 2024 $741 · 2025 $1,763
Food & beverage: $1,763
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $330 |
| ABBVIE INC. | 17 | $323 |
| Otsuka America Pharmaceutical, Inc. | 12 | $296 |
| Alkermes, Inc. | 8 | $193 |
| Janssen Pharmaceuticals, Inc | 8 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $168 |
| Teva Pharmaceuticals USA, Inc. | 6 | $115 |
| Lundbeck LLC | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
Products named: COBENFY, VRAYLAR, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, CAPLYTA, REXULTI, UZEDY.
Industry payments across PA — which companies pay providers there.
